Navamedic ASA (FRA:N1A) YoY EBITDA Growth : -48.95% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Navamedic ASA YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Navamedic ASA's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -48.95%.

Navamedic ASA's EBITDA per Share for the six months ended in Dec. 2023 was €0.10.

Navamedic ASA YoY EBITDA Growth Historical Data

The historical data trend for Navamedic ASA's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navamedic ASA YoY EBITDA Growth Chart

Navamedic ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-232.31

22.09

204.48

304.29

-46.64

Navamedic ASA Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															407.14	259.26	341.86	-45.36	-48.95

Navamedic ASA YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Navamedic ASA's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.151	-	0.283)	/	\| 0.283 \|
=	-46.64 %

Navamedic ASA's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0.097	-	0.19)	/	\| 0.19 \|
=	-48.95 %

Navamedic ASA YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Navamedic ASA's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Navamedic ASA (FRA:N1A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Navamedic ASA (FRA:N1A) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

NAVA:Norway

Address

Henrik Ibsensgate 100, Solli Plass, Lysaker, NOR, N-0255

Website

https://www.navamedic.com

Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributing pharmaceuticals and medical nutrition products to hospitals, pharmacies, and patients, bought from product suppliers and manufacturers in Europe and other places. Its product categories include Medical nutrition, Consumer health, Branded generics, and Specialty pharma.

Navamedic ASA (FRA:N1A) Headlines

No Headlines